Krystal Biotech Appoints Laurent Goux as General Manager of Europe
“We are excited to welcome Laurent to the Krystal team at such a pivotal time for our lead investigational program, B-VEC for DEB, and the rest of our growing rare disease pipeline,” said
In his latest role as Head of Global Strategic Marketing and Market Access at Galderma, Laurent led the global commercial organization through multiple successes and launches of dermatologic disease medicines. He was responsible for leading the Global Market Access, Pricing, HEOR and Strategic Marketing. Previously, Laurent served as Galderma’s Regional Director EMEA-Emerging Markets, where he led regional commercial development, opened several new markets and managed multiple partners. Prior to that, Laurent held various roles across General Management, Business Development and Finance with Galderma and
“I am delighted to be part of a dedicated team focused on developing novel treatments for debilitating rare diseases,” Laurent commented. “Krystal’s redosable gene delivery platform shows great promise, and I look forward to setting up operations in
About Krystal Biotech
CONTACTS: | |
Investors: | Media: |
Whitney Ijem | |
TellMed Strategies | |
wijem@krystalbio.com | mary.coyle@tmstrat.com |
Source: Krystal Biotech, Inc.